DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Ironwood Pharma (NASDAQ: IRWD)

14.79 -0.27 (-1.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IRWD $14.79 -1.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.03
Previous Close $15.06
Daily Range $14.20 - $15.21
52-Week Range $9.01 - $15.95
Market Cap $2.1B
P/E Ratio -9.78
Dividend (Yield) $0.00 (0.0%)
Volume 1,643,072
Average Daily Volume 777,388
Current FY EPS -$1.33

Sector

Healthcare

Industry

Healthcare Information Services

Ironwood Pharma (IRWD) Description

Ironwood Pharmaceuticals Inc. is an entrepreneurial pharmaceutical company that discovers develops and intends to commercialize differentiated medicines that improve patients’ lives. Website: http://www.ironwoodpharma.com/

News & Commentary Rss Feed

5 Things Actavis plc's Management Wants You to Know

Specialty and generic drugmaker Actavis plc reported another monster quarter last week. Here are five things management wants investors to know going forward.

Ironwood Pharmaceuticals Advances IW-9179 to Phase IIa - Analyst Blog

Synergy Pharmaceuticals Drug Fares Well in Phase II Study - Analyst Blog

Ironwood Pharmaceuticals' Q3 Loss Narrower than Expected - Analyst Blog

Ironwood Pharmaceuticals (IRWD) Stock Downgraded Today at Cantor Fitzgerald

Analysts' Actions: American Electric, Cornerstone OnDemand, CST Brands

Ironwood Pharmaceuticals' (IRWD) CEO Peter Hecht on Q3 2014 Results - Earnings Call Transcript

Ironwood Pharmaceuticals (IRWD) Q3 2014 Results - Earnings Call Webcast

Ironwood Presents IW-9179 Phase IIa Data At American College Of Gastroenterology 2014 Annual Scienti

Ironwood Presents IW-9179 Phase IIa Data At American College Of Gastroenterology 2014 Annual Scientific Meeting

Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog

Ironwood/Actavis Move Linzess into Phase II Study for OIC - Analyst Blog

See More IRWD News...

IRWD's Top Competitors

IRWD $14.79 (-1.79%)
Current stock: IRWD
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB